Mixed anxiety/depression symptoms in a large cancer cohort: Prevalence by cancer type

Psychosomatics

Volumn 50, Issue 4, 2009, Pages 383-391

  Brintzenhofe Szoc, Karlynn M ^a   Levin, Tomer T ^a   Li, Yuelin ^a   Kissane, David W ^a   Zabora, James R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BREAST CANCER; BRIEF SYMPTOM INVENTORY; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DEPENDENT VARIABLE; DEPRESSION; DISTRESS SYNDROME; FEMALE; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIXED ANXIETY AND DEPRESSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OROPHARYNX CANCER; OUTPATIENT; PANCREAS CANCER; PHENOTYPE; PREDICTOR VARIABLE; PREVALENCE; STOMACH CANCER;

ANXIETY DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; ROC CURVE;

EID: 69249105384     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.4.383     Document Type: Article

References (50)

1. Coryell W, Endicott J, Andreasen NC, et al: Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1988; 145:293-300 (Pubitemid 18078307)
2. Fava M, Uebelacker LA, Alpert JE, et al: Major depressive subtypes and treatment response. Biol Psychiatry 1997; 42:568-576 (Pubitemid 27425475)
3. Gaynes BN, Magruder KM, Burns BJ, et al: Does a coexisting anxiety disorder predict persistence of depressive illness in primary-care patients with major depression? Gen Hosp Psychiatry 1999; 21:158-167
4. Brown C, Schulberg HC, Madonia MJ, et al: Treatment outcomes for primary-care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996; 153:1293-1300 (Pubitemid 26334202)
5. Vollrath M, Angst J: Outcome of panic and depression in a seven-year follow-up: results of The Zurich Study. Acta Psychiatr Scand 1989; 80:591-596 (Pubitemid 20046945)
6. McLaughlin TP, Khandker RK, Kruzikas DT, et al: Overlap of anxiety and depression in a managed-care population: prevalence and association with resource utilization. J Clin Psychiatry 2006; 67:1187-1193
7. Bakish D: The patient with comorbid depression and anxiety: the unmet need. J Clin Psychiatry 1999; 60(suppl 6):20-24 (Pubitemid 29210627)
8. Pollack M: Comorbid anxiety and depression (review). J Clin Psychiatry 2005; 66(suppl 8):22-29
9. Londborg PD, Smith WT, Glaudin V, et al: Short-term co-therapy with clonazepam and fluoxetine: anxiety, sleep disturbance, and core symptoms of depression. J Affect Disord 2000; 61:73-79
10. Clark LA, Watson D: Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100:316-336
11. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington DC, American Psychiatric Association, 2000
12. Zinbarg RE, Barlow DH, Liebowitz M, et al: The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry 1994; 151:1153-1162 (Pubitemid 24240958)
13. Roy-Byrne P, Katon W, Broadhead WE, et al: Subsyndromal ("mixed") anxiety-depression in primary care. J Gen Intern Med 1994; 9:507-512 (Pubitemid 24286803)
14. Katon W, Roy-Byrne PP: Mixed anxiety and depression. J Abnorm Psychol 1991; 100:337-345
15. Andreasen NC, Hoenk PR: The predictive value of adjustment disorders: a follow-up study. Am J Psychiatry 1982; 139:584-590
16. Strain JJ, Smith GC, Hammer JS, et al: Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry 1998; 20:139-149
17. Watson D, Clark L: The PANAS-X: Manual for the Positive and Negative Affect Schedule, Expanded Form, The University of Iowa, 1994
18. Crawford JR, Henry JD: The Positive and Negative Affect Schedule (PANAS): construct validity, measurement properties, and normative data in a large, non-clinical sample. Br J Clin Psychol 2004; 43(Pt 3):245-265
19. Ostir GV, Smith PM, Smith D, et al: Reliability of the Positive and Negative Affect Schedule (PANAS) in medical rehabilitation. Clin Rehabil 2005; 19:767-769 (Pubitemid 41489531)
20. Krueger RF, Finger MS: Using item-response theory to understand comorbidity among anxiety and unipolar mood disorders. Psychol Assess 2001; 13:140-151
21. Dohrenwend BP, Shrout PE, Egri G, et al: Nonspecific psychological distress and other dimensions of psychopathology: measures for use in the general population. Arch Gen Psychiatry 1980; 37:1229-1236 (Pubitemid 11241577)
22. Clarke DM, Kissane DW: Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 2002; 36:733-742
23. Clarke DM, Kissane DW, Trauer T, et al: Demoralization, anhedonia, and grief in patients with severe physical illness. World Psychiatry 2005; 4:96-105
24. Kendler KS, Prescott CA, Myers J, et al: The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003; 60:929-937 (Pubitemid 37122313)
25. Kendler KS, Hettema JM, Butera F, et al: Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003; 60:789-796 (Pubitemid 36960910)
26. Regier DA, Rae DS, Narrow WE, et al: Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 34(suppl):24-28
27. Conway K, Compton W, Stinson F, et al: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychol 2006; 67:247-257 (Pubitemid 43357471)
28. Brown TA, Campbell LA, Lehman CL, et al: Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001; 110:585-599
29. Moffitt T, Harrington H, Caspi A, et al: Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007; 64:651-660 (Pubitemid 46878666)
30. Zabora J, Brintzenhofe-Szoc K, Curbow B, et al: The prevalence of psychological distress by cancer site. Psychooncology 2001; 10:19-28 (Pubitemid 32106774)
31. Pandey M, Devi N, Thomas B, et al: Distress overlaps with anxiety and depression in patients with head and neck cancer. Psychooncology 2007; 16:582-586 (Pubitemid 47039559)
32. Cassileth B, Lusk E, Hutter R, et al: Concordance of depression and anxiety in patients with cancer. Psychol Rep 1984; 54:588-590 (Pubitemid 14069365)
33. Roth A, Kornblith A, Batel-Copel L, et al: Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998; 82:1904-1908 (Pubitemid 28208646)
34. Carney CP, Jones L, Woolson RF, et al: Relationship between depression and pancreatic cancer in the general population. Psychosom Med 2003; 65:884-888 (Pubitemid 37163399)
35. Massie M: Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32:57-71
36. Musselman DL, Miller AH, Porter MR, et al: Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001; 158:1252-1257
37. Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595-605
38. Derogatis L, Spencer P: The Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual, I. Baltimore, MD, 1982
39. Aben I, Verhey F, Lousberg R, et al: Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as screening instruments for depression in stroke patients. Psychosomatics 2002; 43:386-393
40. Payne DK, Hoffman RG, Theodoulou M, et al: Screening for anxiety and depression in women with breast cancer. psychiatry and medical oncology gear up for managed care. Psychosomatics 1999; 40:64-69 (Pubitemid 29056582)
41. Stukenberg K, Dura J, Kiecolt-Glaser J: Depression screening scale validation in an elderly, community-dwelling population. Psychol Assess 1990; 2:134-138
42. Agresti A: Categorical Data Analysis. Hoboken, NJ, Wiley, 2002
43. Derogatis LR, Morrow GR, Fetting JH, et al: The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249:751-757
44. Farber JM, Weinerman BH, Kuypers JA: Psychosocial distress of oncology patients. J Psychosocial Oncol 1984; 2:109-118
45. Stefanek ME, Derogatis LR, Shaw A: Psychosocial distress among oncology outpatients. Psychosomatics 1987; 28:530-539
46. Rush AJ, Trivedi MH, Ibrahim HM, et al: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54:573-583 (Pubitemid 37289444)
47. Chochinov HM, Wilson KG, Enns M, et al: "Are you depressed?" screening for depression in the terminally ill. Am J Psychiatry 1997; 154:674-676
48. Kelly B, McClement S, Chochinov HM: Measurement of psychological distress in palliative care. Palliat Med 2006; 20:779-789 (Pubitemid 46040129)
49. Lydiatt W, Denman D, McNeilly DP, et al: A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134:528-535 (Pubitemid 351724385)
50. Widiger TA, Samuel DB: Diagnostic categories or dimensions? a question for the Diagnostic and Statistical Manual Of Mental Disorders-5th Edition. J Abnorm Psychol 2005; 114:494-504 (Pubitemid 41746988)